ProShare Advisors’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.9K Sell
24,706
-2,961
-11% -$6.46K ﹤0.01% 1982
2025
Q1
$75.5K Sell
27,667
-6,795
-20% -$18.6K ﹤0.01% 1887
2024
Q4
$143K Buy
34,462
+8,481
+33% +$35.3K ﹤0.01% 1982
2024
Q3
$101K Buy
25,981
+7,828
+43% +$30.5K ﹤0.01% 1880
2024
Q2
$71.2K Sell
18,153
-4,809
-21% -$18.9K ﹤0.01% 1705
2024
Q1
$96.2K Buy
22,962
+1,878
+9% +$7.87K ﹤0.01% 1825
2023
Q4
$99.1K Buy
21,084
+2,964
+16% +$13.9K ﹤0.01% 1782
2023
Q3
$56.5K Buy
18,120
+87
+0.5% +$271 ﹤0.01% 1704
2023
Q2
$82.8K Buy
18,033
+585
+3% +$2.69K ﹤0.01% 1724
2023
Q1
$86.4K Sell
17,448
-2,187
-11% -$10.8K ﹤0.01% 1616
2022
Q4
$107K Buy
19,635
+1,485
+8% +$8.11K ﹤0.01% 1640
2022
Q3
$118K Buy
18,150
+467
+3% +$3.04K ﹤0.01% 1528
2022
Q2
$83K Sell
17,683
-11,455
-39% -$53.8K ﹤0.01% 1639
2022
Q1
$204K Buy
+29,138
New +$204K ﹤0.01% 1875